At The University of Kansas Cancer Center, we are on a mission to conquer all cancers.
We are the only National Cancer Institute-designated cancer center in the region, and 1 of only 71 in the nation, to receive this elite distinction. NCI-designated cancer centers are recognized for their scientific excellence, including their depth and breadth of research. They are the backbone of innovative research and care across the country, helping to pioneer today’s most groundbreaking advances in cancer treatment.
Examples of our efforts to reduce the burden of cancer include:
- Developing a novel drug to treat bladder cancer – the first new treatment for bladder cancer in more than 2 decades.
- As one of just 14 National Cancer Institute’s Community Oncology Research Program (NCORP) minority/underserved (MU) community sites, expanding the reach of cancer clinical trials to Kansas’ rural communities.
- Studying rosemary extract as a therapy to keep breast cancer from progressing.
- Educating groups at increased risk for colorectal cancer about the importance of regular screenings.
- Pivoting to address the COVID-19 crisis, especially as it relates to cancer patients, a uniquely vulnerable population.
Countdown to Comprehensive
Over the next decade, the number of cancer diagnoses are predicted to increase by 50 percent. One in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime.
This year, the cancer center will be applying for the highest level of NCI designation, Comprehensive designation. It is the NCI’s premier ranking awarded to the very best cancer centers. To attain this distinction, the cancer center must demonstrate significant depth and breadth in basic, clinical and translational research, with a clear focus on the cancers most affecting our communities.
What does NCI Comprehensive designation mean for our patients, their families and our community? It means higher survival rates and fewer cancer cases overall. More lives saved.
Join us on our quest to conquer all cancers.
